Trial
NCT02240706
Phase I/II Trial to Investigate BI 836858 in Myelodysplastic Syndromes
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Boehringer Ingelheim
Collaborators
—
Condition
Myelodysplastic Syndromes
Intervention
Best Supportive Care
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-12-21